✦ LIBER ✦

Suppression of surfactant protein A by an epidermal growth factor receptor tyrosine kinase inhibitor exacerbates lung inflammation

✍ Scribed by Akira Inoue; Hong Xin; Takuji Suzuki; Masahiko Kanehira; Yoshio Kuroki; Tatsuro Fukuhara; Toshiaki Kikuchi; Makoto Maemondo; Toshihiro Nukiwa; Yasuo Saijo

Book ID: 108584239
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 254 KB
Volume: 99
Category: Article
ISSN: 1347-9032
DOI: 10.1111/j.1349-7006.2008.00857.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Blockage of epidermal growth factor rece

Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma

✍ Yuqing Liu; Ronnie T.P. Poon; Weibin Shao; Xiaoli Sun; Hui Chen; Tsz Wai Kok; Sh 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 404 KB

Acneiform eruptions caused by an epiderm

Acneiform eruptions caused by an epidermal growth factor receptor-tyrosine kinase inhibitor ZD 1839

✍ Gavin A Wong; Simon Nigen; Scott Walsh; Neil Shear 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 53 KB

A review of erlotinib – an oral, selecti

A review of erlotinib – an oral, selective epidermal growth factor receptor tyrosine kinase inhibitor

✍ Iyer, Renuka; Bharthuar, Anubha 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 258 KB

Inhibition of tyrosine kinase activity d

Inhibition of tyrosine kinase activity decreases expression of surfactant protein A in a human lung adenocarcinoma cell line independent of epidermal growth factor receptor

✍ Jonathan M Klein; Troy A McCarthy 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 463 KB

Metabolic disposition of gefitinib, an e

Metabolic disposition of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat, dog and man

✍ McKillop, D.; Hutchison, M.; Partridge, E. A.; Bushby, N.; Cooper, C. M. F.; Cla 📂 Article 📅 2004 🏛 Informa plc 🌐 English ⚖ 275 KB

Proteomic Signature Corresponding to the

Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma

✍ Okano, T.; Kondo, T.; Fujii, K.; Nishimura, T.; Takano, T.; Ohe, Y.; Tsuta, K.; 📂 Article 📅 2007 🏛 American Association for Cancer Research 🌐 English ⚖ 270 KB